|
mutLBSgeneDB |
| |
| |
| |
| |
| |
| |
|
| Gene summary for ADAP1 |
 Gene summary |
| Basic gene Info. | Gene symbol | ADAP1 |
| Gene name | ArfGAP with dual PH domains 1 | |
| Synonyms | CENTA1|GCS1L|p42IP4 | |
| Cytomap | UCSC genome browser: 7p22.3 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001284308.1, NM_001284309.1,NM_001284310.1,NM_001284311.1,NM_006869.3, | |
| Description | arf-GAP with dual PH domain-containing protein 1centaurin, alpha 1centaurin-alphacentaurin-alpha-1cnt-a1putative MAPK-activating protein PM25 | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 608114 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000105963 | ||
| HPRD : 09733 | ||
| Vega : OTTHUMG00000023380 | ||
| Protein | UniProt: O75689 go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_ADAP1 | |
| BioGPS: 11033 | ||
| Pathway | NCI Pathway Interaction Database: ADAP1 | |
| KEGG: ADAP1 | ||
| REACTOME: ADAP1 | ||
| Pathway Commons: ADAP1 | ||
| Context | iHOP: ADAP1 | |
| ligand binding site mutation search in PubMed: ADAP1 | ||
| UCL Cancer Institute: ADAP1 | ||
| Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. | |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO Term | PubMed ID | GO:0043547 | positive regulation of GTPase activity | 10333475 |
| Top |
| Ligand binding site mutations for ADAP1 |
| Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.)  : non-synonymous mutation on LBS, Circle size denotes number of samples. |
 |
| Cancer type specific mutLBS sorted by frequency |
| LBS | AAchange of nsSNV | Cancer type | # samples | R226 | K227E | GBM | 1 | E67 | K67M | KIRC | 1 | V219 | R217S | LUAD | 1 | L289 | D289Y | SKCM | 1 | Y284 | R282W | STAD | 1 |
| cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
| Top |
| Protein structure related information for ADAP1 |
| Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
 : nsSNV at non-LBS : nsSNV at LBS |
 |
| nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
| LBS | AAchange of nsSNV | Relative stability change |
| (MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
| Structure image for ADAP1 from PDB |
| Top |
| Differential gene expression and gene-gene network for ADAP1 |
| Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
| Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
| Top |
| Top |
| Phenotype information for ADAP1 |
| Gene level disease information (DisGeNet) |
| Disease ID | Disease name | # PubMed | Association type |
| Mutation level pathogenic information (ClinVar annotation) |
| Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
| Top |
| Pharmacological information for ADAP1 |
| Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
 |
| Drug information targeting mutLBSgene (Approved drugs only) |
| Drug status | DrugBank ID | Name | Type | Drug structure |
| Gene-centered ligand-gene interaction network |
 |
| Ligands binding to mutated ligand binding site of ADAP1 go to BioLip |
| Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | UNX | UNKNOWN ATOM OR LIGAND | 3feh | A | E67 | UNX | UNKNOWN ATOM OR LIGAND | 3feh | A | L289 | UNX | UNKNOWN ATOM OR LIGAND | 3fm8 | D | R226 | UNX | UNKNOWN ATOM OR LIGAND | 3fm8 | D | V219 | IP9 | L-A-PHOSPHATIDYL-D-MYO-INOSITOL 3,4,5-TRIPHOSPHATE,DIOCTANOYL | 3lju | X | Y284 |
| Top |
| Conservation information for LBS of ADAP1 |
| Multiple alignments for O75689 in multiple species |
| LBS | AA sequence | # species | Species |
 |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |